6 news items
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
STOK
6 May 24
ability to fund development activities and achieve development goals; the Company's ability to protect its intellectual property; the direct
Stoke Therapeutics Appoints Thomas Leggett As Chief Financial Officer, Succeeds Stephen Tulipano Who Resigned His Position As Stoke's CFO Effective Tuesday, May 7
STOK
29 Apr 24
on our goal of delivering the first potential disease-modifying therapy to patients with Dravet syndrome," said Edward M. Kaye, M.D., Chief Executive
Garry Menzel joins GHO Capital as Operating Partner
ADAP
BDTX
DVA
23 Apr 24
am excited to support GHO Capital, as Europe's leading healthcare specialist private equity firm, to pursue the same goal. Their relentless focus
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
STOK
17 Apr 24
goals; and other risks and uncertainties described under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
STOK
27 Mar 24
statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy
xqr97szbqbxgjbeuzd5l4aekzlh2qdqnsv
STOK
26 Mar 24
of the offering and the use thereof. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek
- Prev
- 1
- Next